NRAS and acute myeloid leukemia: Furthermore, the mutational pattern within the defined set of AML driver mutations studied and within the resolution applied was not altered in the 2 samples analyzed, apart from a loss of a rare subclone carrying an NRAS mutation (VAF 5%) in t-PDX of AML-372 (Fig. 3F; S2 Table).